best glp 1 programs Long-term Success of GLP-1s Hinges on More Than Just a Prescription Best Exercise Program for Women

In the Middle East & Africa (MEA) region, the adoption of GLP-1 receptor agonists is heterogeneous but increasing, with the market estimated to be USD 920 million in 2025 and estimated to rise to USD 2.8 billion in 2035 with a CAGR of 11.8%

Our Experience At Rheumatologist OnCall, in the past two years, our patients have experienced: Remarkable drops in pain, morning stiffness (even with microdoses) Surge in energy, improved sleep, and confidence Steady, sustainable weight loss Reduced need for or the ability to taper steroids, DMARDs, and biologics For carefully selected patients, GLP-1 therapy has been truly life-changing

Increasing skin cell turnover makes the skin healthier, younger, and more radiant

Exenatide and lixisenatide both have relatively short half-lives and are considered short-acting GLP-1 RAs